Monday, 23 February 2026
  
Login

Australia's most trusted
source of pharma news

Monday, 23 February 2026
Ascott 2
Ascott 2
Fallen blockbusters shake up PBS

Loss of exclusivity saw a shake-up in the highest PBS earners of 2025, although one beast of a drug stayed in the list despite the launch of generic competition.

Aussie company sells for $1.6B
After making its mark selling compounded semaglutide via telehealth, this company has been snapped up by a US giant
TODAY
TGA approves new ADC
This pharma has finally registered its first-in-class drug, months after securing the PBAC's recommendation
TODAY Approvals Action
Staff exit over work policy gap
Pharma funded survey finds 39 per cent of employees undergoing fertility treatment are leaving or considering leaving their jobs
20 February
20+ companies hit PBS bottleneck
Find out who is in the running to secure a PBS listing in March, with seven brand-new drugs on the cards
19 February
Is this pharma's hottest career?
Aussie webinar swamped, underlining the popularity of this function and raising questions about career paths
18 February
Roche taps Aussie for big HQ job
After 12 years in his current Melbourne-based role, this high-flyer is packing his bags for Basel and an impressive global position
18 February
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (11)

Clinical & Medical, R&D (6)

Regulatory, Pharmacovigilance & QA (5)

Executive Roles (4)

Other (16)

Obesity battle, now a war of words?
When it comes to controlling the narrative around obesity drugs, one company is blitzing it by winning hearts and minds
20 February
Pharma execs swamp job webinar
Registrations go viral so could this be pharma's hottest role? Plus the other most popular stories this week
20 February  Your Week in 5 Minutes
Big year for novel drug approvals
More than 40 novel drugs secured their first approval last year but only a tiny fraction reached Australia. See the list
20 February
Seqirus wipes out rival's patents
A couple of patents covering mRNA vaccines are no longer valid, as two vaccine giants jostle over access to the market
20 February
Meet Pharma's Most Influential
TIME has released its list of the 100 people most influential in health, find out which pharma leaders made the cut
19 February
Novo backs Aussie town with $3M
The obesity giant is funding a program to improve children's health through nourishing food and exercise, in this fast-growing area
19 February
CSL strikes $100M deal with Lilly
Licensing agreement for a promising therapeutic candidate gives Lilly rights in all potential indications... except one
19 February
Deal failure sparks damages fight
ASX listed Mayne Pharma has taken US-based Cosette to court seeking "substantial damages" after a sale agreement fell over
19 February
China charges AZ with illegal trade
Two former senior executives also facing charges with a $25 million fine looming for the company if it is found liable
18 February
Trial consent now much easier
New documentation will make it simpler for pharma researchers to get informed consent from patients wanting to participate in trials
18 February
Govt blasted over drug shortages
Aussie clinicians call for a national advisory service after being forced into high-stake treatment decisions risking patient safety
18 February
Look who's won a leadership role
Aussie pharma executives are stepping into top roles, either switching companies or winning internal promotions
17 February
Judge shields $130M AZ market
Unprecedented speedy court decision has saved AstraZeneca from premature generic competition in its biggest market in Australia
17 February
Aussies cashed up for US spin-off
Launched by Health Minister Mark Butler just two years ago, this company is moving fast to advance its lead program in prostate cancer
17 February
PiF advertise
PiF advertise
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.